Re: [CANSLIM] AAII

From: "JSherm" <joani@mindspring.com>
Subject: Re: [CANSLIM] AAII
Date: Thu, 4 Apr 2002 12:12:53 -0500

Next Article (by Date): [CANSLIM] AHS "Edward W. Gjertsen II"
Articles sorted by: [Date] [Author] [Subject]

Briefing.com update

aaiPharma shares hit by Sell rating (33.08 -4.91) -- Update --
 More details on the 11:31 comment: Sturza's Institutional Research
apparently issued the report on AAII; we're hearing that they initiated
coverage with a Sell rating and a $25 target, saying that company can hit
2002 EPS estimates but that its growth rate will be unsustainable without
further acquisitions given that the company does not have a drug development
track record; also cites concern that company will need a secondary offering
to strengthen balance sheet and finance acquisitions

jps

- -
- -To subscribe/unsubscribe, email "majordomo@xmission.com"
- -In the email body, write "subscribe canslim" or
- -"unsubscribe canslim".  Do not use quotes in your email.

Next Article (by Date): [CANSLIM] AHS "Edward W. Gjertsen II"
Articles sorted by: [Date] [Author] [Subject]

Go to Jeff Salisbury LWGate Home Page.